A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome

Clinical trial NCT00282399 · TERMINATED

Trial details

NCT number: NCT00282399
Sponsor: Eisai Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome

Start date: 2006-10-01
Primary completion: 2008-10-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.